...
首页> 外文期刊>The Journal of heart valve disease >Fixed-dose versus adjusted-dose warfarin in patients with prosthetic heart valves in a peri-urban impoverished population.
【24h】

Fixed-dose versus adjusted-dose warfarin in patients with prosthetic heart valves in a peri-urban impoverished population.

机译:城郊贫困人群人工瓣膜患者的固定剂量与调整剂量的华法林。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND AIMS OF THE STUDY: Patients with mechanical heart valves are critically dependent upon adequate anticoagulation. The present patients are young, geographically dispersed and socioeconomically deprived. Hospital attendance is erratic, and compliance with conventional anticoagulation difficult. The need exists for an alternative method of anticoagulation that requires neither regular visits nor adjustment of the warfarin dose. METHODS: A five-year prospective randomized double-blind study was undertaken to compare the efficacy and safety of a predetermined, individualized fixed-dose versus adjusted-dose warfarin. Postopoeratively, 296 patients, after an initial dose-finding phase (International Normalized Ratio (INR) 2.0 - 3.5), were randomized to either fixed-dose or adjusted-dose warfarin. RESULTS: For the intention-to-treat analysis, the groups were well-matched with regard to baseline characteristics. Among patients on fixed-dose warfarin, 63% of INRs were in the range 2.0 - 4.5 compared with 64% in patients on adjusted-dose warfarin. The mean follow up period was 2.4 years in both groups; total follow up was 725 patient-years. There were seven deaths in the fixed-dose warfarin group, and five in the adjusted-dose group (p = 0.52). Thirteen major thrombotic events, occurred in the fixed-dose warfarin group, and four in the adjusted-dose group (p = 0.02). Twelve major hemorrhagic events occurred in each group. CONCLUSION: In this predominantly young, impoverished population, despite similar overall INR control, fixed-dose warfarin was associated with an increase in thromboembolic events, but no significant increase in mortality or hemorrhagic events. Fixed-dose warfarin may be an acceptable option where conventional anticoagulation is impracticable. In particular, the study highlighted the difficulties of adequate anticoagulation in a population where compliance is erratic and often non-existent.
机译:研究背景和目的:机械心脏瓣膜患者严重依赖于充分的抗凝治疗。目前的患者是年轻的,地理上分散并且在社会经济上被剥夺。医院出诊率不稳定,难以遵守常规抗凝治疗。需要一种抗凝的替代方法,该方法既不需要定期检查,也不需要调整华法林剂量。方法:进行了为期五年的前瞻性随机双盲研究,比较了预先确定的个性化固定剂量华法林与调整剂量华法林的疗效和安全性。术后,296名患者在初始剂量确定阶段(国际标准化比率(INR)2.0-3.5)后被随机分为固定剂量或调整剂量的华法林。结果:为了进行意向治疗分析,各组在基线特征方面匹配良好。在使用固定剂量华法林的患者中,有63%的INR介于2.0-4.5之间,而使用调整剂量华法林的患者中有64%的INR。两组的平均随访时间为2。4年。总随访时间为725患者-年。固定剂量的华法林组有7例死亡,调整剂量组有5例死亡(p = 0.52)。固定剂量的华法林组发生了13次主要血栓事件,而调整剂量组则发生了4次(p = 0.02)。每组发生十二次重大出血事件。结论:在这个年轻,贫困的人群中,尽管总体INR控制相似,但固定剂量的华法令与血栓栓塞事件增加有关,但死亡率或出血性事件没有明显增加。在常规抗凝治疗不可行的情况下,固定剂量的华法林可能是可接受的选择。该研究特别强调了在依从性不稳定且经常不存在的人群中进行充分抗凝治疗的困难。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号